Search

everythinglearnresearchcommunity

for

Search:↓

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Skin lymphatic vessels are essential for hair growth.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Effective treatments for severe alopecia areata are still lacking.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Long COVID patients have more health issues than non-infected people.

Genomic approach finds new possible treatments for hair loss.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.